These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 25136783)
21. 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Richette P; Doherty M; Pascual E; Barskova V; Becce F; Castaneda J; Coyfish M; Guillo S; Jansen T; Janssens H; Lioté F; Mallen CD; Nuki G; Perez-Ruiz F; Pimentao J; Punzi L; Pywell A; So AK; Tausche AK; Uhlig T; Zavada J; Zhang W; Tubach F; Bardin T Ann Rheum Dis; 2020 Jan; 79(1):31-38. PubMed ID: 31167758 [TBL] [Abstract][Full Text] [Related]
22. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Mikuls TR; Farrar JT; Bilker WB; Fernandes S; Saag KG Rheumatology (Oxford); 2005 Aug; 44(8):1038-42. PubMed ID: 15870145 [TBL] [Abstract][Full Text] [Related]
23. Hyperuricaemia elevates circulating CCL2 levels and primes monocyte trafficking in subjects with inter-critical gout. Grainger R; McLaughlin RJ; Harrison AA; Harper JL Rheumatology (Oxford); 2013 Jun; 52(6):1018-21. PubMed ID: 23204548 [TBL] [Abstract][Full Text] [Related]
24. Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study. Trifirò G; Morabito P; Cavagna L; Ferrajolo C; Pecchioli S; Simonetti M; Bianchini E; Medea G; Cricelli C; Caputi AP; Mazzaglia G Ann Rheum Dis; 2013 May; 72(5):694-700. PubMed ID: 22736095 [TBL] [Abstract][Full Text] [Related]
25. Update on gout and hyperuricemia. Baker JF; Schumacher HR Int J Clin Pract; 2010 Feb; 64(3):371-7. PubMed ID: 19909378 [TBL] [Abstract][Full Text] [Related]
26. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan. Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262 [TBL] [Abstract][Full Text] [Related]
27. The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden. Kapetanovic MC; Nilsson P; Turesson C; Englund M; Dalbeth N; Jacobsson L Arthritis Res Ther; 2018 Aug; 20(1):190. PubMed ID: 30157929 [TBL] [Abstract][Full Text] [Related]
28. Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout. Feher MD; Hepburn AL; Hogarth MB; Ball SG; Kaye SA Rheumatology (Oxford); 2003 Feb; 42(2):321-5. PubMed ID: 12595630 [TBL] [Abstract][Full Text] [Related]
29. Drug-induced hyperuricaemia and gout. Ben Salem C; Slim R; Fathallah N; Hmouda H Rheumatology (Oxford); 2017 May; 56(5):679-688. PubMed ID: 27498351 [TBL] [Abstract][Full Text] [Related]
30. Managing hyperuricemia and gout in chronic kidney disease: a clinical conundrum. Premachandra KH; Day RO; Roberts DM Curr Opin Nephrol Hypertens; 2021 Mar; 30(2):245-251. PubMed ID: 33399392 [TBL] [Abstract][Full Text] [Related]
31. [Gout as a systemic disease: systemic manifestations and comorbidities of hyperuricaemia]. Glasnović M Reumatizam; 2012; 59(2):119-32. PubMed ID: 23745468 [TBL] [Abstract][Full Text] [Related]
32. Prevalence and discrimination of OMERACT-defined elementary ultrasound lesions of gout in people with asymptomatic hyperuricaemia: A systematic review and meta-analysis. Stewart S; Maxwell H; Dalbeth N Semin Arthritis Rheum; 2019 Aug; 49(1):62-73. PubMed ID: 30709689 [TBL] [Abstract][Full Text] [Related]
33. Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution. Stamp L; Dalbeth N Semin Arthritis Rheum; 2017 Feb; 46(4):457-464. PubMed ID: 27591828 [TBL] [Abstract][Full Text] [Related]
36. Incident gout and erectile dysfunction: is hyperuricaemia the elephant in the room? Abhishek A; Doherty M Arthritis Res Ther; 2017 Aug; 19(1):184. PubMed ID: 28797283 [TBL] [Abstract][Full Text] [Related]
37. Are ultrasound features at the first metatarsophalangeal joint associated with clinically-assessed pain and function? A study of people with gout, asymptomatic hyperuricaemia and normouricaemia. Stewart S; Dalbeth N; Vandal AC; Allen B; Miranda R; Rome K J Foot Ankle Res; 2017; 10():22. PubMed ID: 28539973 [TBL] [Abstract][Full Text] [Related]
38. Improving cardiovascular and renal outcomes in gout: what should we target? Richette P; Perez-Ruiz F; Doherty M; Jansen TL; Nuki G; Pascual E; Punzi L; So AK; Bardin T Nat Rev Rheumatol; 2014 Nov; 10(11):654-61. PubMed ID: 25136785 [TBL] [Abstract][Full Text] [Related]
39. [Practice guideline for patients with hyperuricemia/gout]. Huang YF; Yang KH; Chen SH; Xie Y; Huang CB; Qing YF; He DY; Wu LJ; Zhan F; Wang XQ; Zhou YQ; Kong QC; Wang K; Schlesinger N; Xu DT; Ma XJ; Gu JR Zhonghua Nei Ke Za Zhi; 2020 Jul; 59(7):519-527. PubMed ID: 32594685 [TBL] [Abstract][Full Text] [Related]
40. Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2. Toyoda Y; Pavelcová K; Klein M; Suzuki H; Takada T; Stiburkova B Arthritis Res Ther; 2019 Oct; 21(1):219. PubMed ID: 31661014 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]